Treosulfan was non-inferior to busulfan when used in combination with fludarabine as a conditioning regimen for allogeneic HSCT for older or comorbid patients.
Oct 9, 2019 · Treosulfan was non-inferior to busulfan when used in combination with fludarabine as a conditioning regimen for allogeneic HSCT for older or ...
Treosulfan was non-inferior to busulfan when used in combination with fludarabine as a conditioning regimen for allogeneic HSCT for older or comorbid patients.
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid ...
Feb 22, 2023 · Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic ...
People also ask
What is conditioning treatment before bone marrow transplant?
What is the conditioning regimen for AML transplant?
What are the conditioning regimens for allogeneic transplant?
What is pre conditioning for stem cell transplant?
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies. · Medicine.
Treo-based conditioning shows better overall survival versus busulfan in MDS patients. Treosulfan recipients had better relapse free survival and event free ...
Feb 21, 2024 · Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid ...
May 26, 2022 · Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and ...
Jul 24, 2021 · Our real-world study confirms that HCT with FluTreo expands the transplant population with favorable outcomes compared to previously used conditions.